Concepts (106)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 4 | 2019 | 986 | 0.580 |
Why?
|
| Trinucleotide Repeat Expansion | 2 | 2012 | 32 | 0.480 |
Why?
|
| DNA Mismatch Repair | 2 | 2012 | 12 | 0.420 |
Why?
|
| DNA Repair Enzymes | 1 | 2012 | 9 | 0.420 |
Why?
|
| Adenosine Triphosphatases | 1 | 2012 | 47 | 0.400 |
Why?
|
| DNA-Binding Proteins | 1 | 2012 | 482 | 0.320 |
Why?
|
| Autoimmunity | 2 | 2019 | 153 | 0.300 |
Why?
|
| DNA, Bacterial | 1 | 2008 | 301 | 0.290 |
Why?
|
| Escherichia coli | 1 | 2008 | 328 | 0.260 |
Why?
|
| B-Lymphocytes | 3 | 2019 | 276 | 0.210 |
Why?
|
| B-Cell Activating Factor | 2 | 2020 | 31 | 0.190 |
Why?
|
| Genomic Instability | 2 | 2012 | 33 | 0.180 |
Why?
|
| Friedreich Ataxia | 2 | 2012 | 44 | 0.180 |
Why?
|
| Cell Differentiation | 2 | 2019 | 395 | 0.170 |
Why?
|
| Nuclear Family | 1 | 2019 | 12 | 0.160 |
Why?
|
| Disease Susceptibility | 1 | 2019 | 72 | 0.160 |
Why?
|
| Plasma Cells | 1 | 2019 | 21 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2019 | 30 | 0.160 |
Why?
|
| Steroids | 1 | 2019 | 55 | 0.160 |
Why?
|
| Immunologic Memory | 1 | 2019 | 58 | 0.160 |
Why?
|
| Gene Expression | 1 | 2020 | 405 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2019 | 162 | 0.150 |
Why?
|
| Serologic Tests | 1 | 2017 | 19 | 0.150 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2017 | 23 | 0.150 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2019 | 132 | 0.150 |
Why?
|
| Terminology as Topic | 1 | 2017 | 52 | 0.140 |
Why?
|
| Sjogren's Syndrome | 1 | 2020 | 256 | 0.140 |
Why?
|
| Humans | 10 | 2020 | 26838 | 0.130 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2019 | 664 | 0.130 |
Why?
|
| Early Diagnosis | 1 | 2015 | 32 | 0.130 |
Why?
|
| Mismatch Repair Endonuclease PMS2 | 1 | 2012 | 2 | 0.110 |
Why?
|
| MutS Homolog 2 Protein | 1 | 2012 | 2 | 0.110 |
Why?
|
| MutS DNA Mismatch-Binding Protein | 1 | 2012 | 6 | 0.110 |
Why?
|
| Ganglia, Spinal | 1 | 2012 | 25 | 0.100 |
Why?
|
| Cerebellum | 1 | 2012 | 41 | 0.100 |
Why?
|
| Autoantibodies | 3 | 2020 | 466 | 0.100 |
Why?
|
| Rec A Recombinases | 2 | 2008 | 6 | 0.100 |
Why?
|
| Mice, Transgenic | 1 | 2012 | 487 | 0.090 |
Why?
|
| INDEL Mutation | 1 | 2008 | 7 | 0.080 |
Why?
|
| Mutation | 1 | 2012 | 819 | 0.080 |
Why?
|
| DNA Replication | 1 | 2008 | 49 | 0.080 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2020 | 254 | 0.080 |
Why?
|
| Sequence Deletion | 1 | 2007 | 65 | 0.070 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2007 | 24 | 0.070 |
Why?
|
| Middle Aged | 4 | 2020 | 6818 | 0.070 |
Why?
|
| Iron-Binding Proteins | 1 | 2007 | 35 | 0.070 |
Why?
|
| Base Sequence | 1 | 2008 | 573 | 0.070 |
Why?
|
| Escherichia coli Proteins | 1 | 2008 | 113 | 0.070 |
Why?
|
| Cytokines | 2 | 2020 | 437 | 0.070 |
Why?
|
| DNA Repair | 1 | 2007 | 82 | 0.070 |
Why?
|
| Adult | 4 | 2020 | 7386 | 0.070 |
Why?
|
| Biomarkers | 2 | 2019 | 731 | 0.060 |
Why?
|
| Animals | 2 | 2019 | 9949 | 0.060 |
Why?
|
| Male | 4 | 2020 | 12859 | 0.050 |
Why?
|
| Mice | 1 | 2012 | 4401 | 0.050 |
Why?
|
| Female | 4 | 2020 | 14455 | 0.050 |
Why?
|
| Tumor Necrosis Factor Ligand Superfamily Member 14 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Chemokine CXCL9 | 1 | 2020 | 3 | 0.040 |
Why?
|
| Chemokine CXCL13 | 1 | 2020 | 7 | 0.040 |
Why?
|
| Interleukin-1alpha | 1 | 2020 | 7 | 0.040 |
Why?
|
| Chemokine CXCL10 | 1 | 2020 | 22 | 0.040 |
Why?
|
| Seroconversion | 1 | 2019 | 4 | 0.040 |
Why?
|
| Interferons | 1 | 2020 | 68 | 0.040 |
Why?
|
| Self Tolerance | 1 | 2019 | 9 | 0.040 |
Why?
|
| Gene Regulatory Networks | 1 | 2020 | 75 | 0.040 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 2019 | 18 | 0.040 |
Why?
|
| Models, Statistical | 1 | 2020 | 118 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 81 | 0.040 |
Why?
|
| Interleukins | 1 | 2020 | 108 | 0.040 |
Why?
|
| Antibodies, Antinuclear | 1 | 2020 | 181 | 0.040 |
Why?
|
| Interferon-gamma | 1 | 2019 | 102 | 0.040 |
Why?
|
| Environment | 1 | 2019 | 60 | 0.040 |
Why?
|
| Antigens | 1 | 2019 | 66 | 0.040 |
Why?
|
| Immunity, Humoral | 1 | 2019 | 46 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2019 | 182 | 0.040 |
Why?
|
| Aged | 2 | 2019 | 5162 | 0.040 |
Why?
|
| Antibodies, Neutralizing | 1 | 2019 | 69 | 0.040 |
Why?
|
| Lymphocyte Activation | 1 | 2019 | 203 | 0.040 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2019 | 106 | 0.040 |
Why?
|
| Alleles | 1 | 2019 | 347 | 0.040 |
Why?
|
| Host-Pathogen Interactions | 1 | 2019 | 89 | 0.040 |
Why?
|
| Neutrophils | 1 | 2019 | 177 | 0.040 |
Why?
|
| Monocytes | 1 | 2019 | 132 | 0.040 |
Why?
|
| United States Virgin Islands | 1 | 2017 | 4 | 0.040 |
Why?
|
| British Virgin Islands | 1 | 2017 | 4 | 0.040 |
Why?
|
| Puerto Rico | 1 | 2017 | 6 | 0.040 |
Why?
|
| Hydroxychloroquine | 1 | 2017 | 19 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2017 | 50 | 0.040 |
Why?
|
| Phenotype | 1 | 2020 | 663 | 0.040 |
Why?
|
| Transcription, Genetic | 1 | 2019 | 399 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2017 | 56 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2019 | 860 | 0.030 |
Why?
|
| Models, Biological | 1 | 2019 | 446 | 0.030 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2019 | 543 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2017 | 472 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 447 | 0.030 |
Why?
|
| Inflammation | 1 | 2020 | 598 | 0.030 |
Why?
|
| Case-Control Studies | 1 | 2017 | 701 | 0.030 |
Why?
|
| Registries | 1 | 2017 | 379 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2019 | 1393 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2017 | 916 | 0.030 |
Why?
|
| Risk Factors | 1 | 2019 | 2013 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2019 | 1339 | 0.030 |
Why?
|
| Aged, 80 and over | 1 | 2017 | 1925 | 0.030 |
Why?
|
| Young Adult | 1 | 2019 | 2582 | 0.020 |
Why?
|
| United States | 1 | 2017 | 2035 | 0.020 |
Why?
|